The Role of BDNF on Aging-Modulation Markers

Area of Science:

• Neuroscience
• Molecular Biology
• Aging Research

Background:

• Neurotrophins, particularly brain-derived neurotrophic factor (BDNF), are crucial for preventing age-related synaptic loss, cerebral atrophy, and cognitive decline.
• BDNF plays a fundamental role in maintaining neuronal health and function during brain aging.

Purpose of the Study:

• To investigate if low-dose BDNF sequentially kinetic activated (SKA) can counteract nervous tissue degeneration and aging.
• To assess BDNF SKA's ability to enhance endogenous protection mechanisms against neurodegeneration.

Main Methods:

• In vitro and in vivo experiments were conducted to evaluate BDNF SKA's effects.
• Studies focused on intestinal absorption (in vitro) and brain function (in vivo).
• Analysis included molecular pathways, receptor TrkB activation, apolipoprotein E, β-Amyloid, and Sirtuin 1 protein levels.

Main Results:

• BDNF SKA was shown to induce endogenous BDNF production via its receptor TrkB.
• The treatment influenced apolipoprotein E expression and affected β-Amyloid and Sirtuin 1 proteins.
• These findings suggest BDNF SKA exerts a fine endogenous regulatory effect on neuron and astrocyte health.

Conclusions:

• BDNF SKA demonstrates potential in counteracting mechanisms underlying nervous tissue degeneration and aging.
• Modulating BDNF turnover through SKA therapy is a promising strategy against brain aging.
• This approach supports endogenous neuroprotection and regeneration pathways.